Explainable prediction model for the human papillomavirus status in patients with oropharyngeal squamous cell carcinoma using CNN on CT images.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 06 2024
Historique:
received: 23 11 2023
accepted: 18 06 2024
medline: 21 6 2024
pubmed: 21 6 2024
entrez: 20 6 2024
Statut: epublish

Résumé

Several studies have emphasised how positive and negative human papillomavirus (HPV+  and HPV-, respectively) oropharyngeal squamous cell carcinoma (OPSCC) has distinct molecular profiles, tumor characteristics, and disease outcomes. Different radiomics-based prediction models have been proposed, by also using innovative techniques such as Convolutional Neural Networks (CNNs). Although some of these models reached encouraging predictive performances, there evidence explaining the role of radiomic features in achieving a specific outcome is scarce. In this paper, we propose some preliminary results related to an explainable CNN-based model to predict HPV status in OPSCC patients. We extracted the Gross Tumor Volume (GTV) of pre-treatment CT images related to 499 patients (356 HPV+ and 143 HPV-) included into the OPC-Radiomics public dataset to train an end-to-end Inception-V3 CNN architecture. We also collected a multicentric dataset consisting of 92 patients (43 HPV+ , 49 HPV-), which was employed as an independent test set. Finally, we applied Gradient-weighted Class Activation Mapping (Grad-CAM) technique to highlight the most informative areas with respect to the predicted outcome. The proposed model reached an AUC value of 73.50% on the independent test. As a result of the Grad-CAM algorithm, the most informative areas related to the correctly classified HPV+ patients were located into the intratumoral area. Conversely, the most important areas referred to the tumor edges. Finally, since the proposed model provided additional information with respect to the accuracy of the classification given by the visualization of the areas of greatest interest for predictive purposes for each case examined, it could contribute to increase confidence in using computer-based predictive models in the actual clinical practice.

Identifiants

pubmed: 38902523
doi: 10.1038/s41598-024-65240-9
pii: 10.1038/s41598-024-65240-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

14276

Subventions

Organisme : Ministero della Salute
ID : RC2024

Informations de copyright

© 2024. The Author(s).

Références

Pytynia, K. B., Dahlstrom, K. R. & Sturgis, E. M. Epidemiology of HPV-associated oropharyngeal cancer. Oral. Oncol. 50, 380–386 (2014).
doi: 10.1016/j.oraloncology.2013.12.019 pubmed: 24461628 pmcid: 4444216
Lechner, M., Liu, J., Masterson, L. & Fenton, T. R. HPV-associated oropharyngeal cancer: Epidemiology, molecular biology and clinical management. Nat. Rev. Clin. Oncol. 19(5), 306–327 (2022).
doi: 10.1038/s41571-022-00603-7 pubmed: 35105976 pmcid: 8805140
Craig, S. G. et al. Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: A two-tier approach. Br. J. Cancer. 120(8), 827–833 (2019).
doi: 10.1038/s41416-019-0414-9 pubmed: 30890775 pmcid: 6474272
Gillison, M. L. et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J. Natl. Cancer Inst. 100, 407–420 (2008).
doi: 10.1093/jnci/djn025 pubmed: 18334711
Lassen, P. et al. Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer. Radiother. Oncol. 113, 310–316 (2014).
doi: 10.1016/j.radonc.2014.11.032 pubmed: 25544647
Rietbergen, M. M. et al. Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. Ann. Oncol. 24(11), 2740–2745 (2013).
doi: 10.1093/annonc/mdt319 pubmed: 23946330
Hibbert, J., Halec, G., Baaken, D., Waterboer, T. & Brenner, N. Sensitivity and specificity of human papillomavirus (HPV) 16 early antigen serology for HPV-driven oropharyngeal cancer: A systematic literature review and meta-analysis. Cancers 13(12), 3010 (2021).
doi: 10.3390/cancers13123010 pubmed: 34208476 pmcid: 8234521
Fujima, N. et al. Prediction of the human papillomavirus status in patients with oropharyngeal squamous cell carcinoma by FDG-PET imaging dataset using deep learning analysis: a hypothesis-generating study. Eur. J. Radiol. 126, 108936 (2020).
doi: 10.1016/j.ejrad.2020.108936 pubmed: 32171912
Sohn, B. et al. Machine learning based radiomic HPV phenotyping of oropharyngeal SCC: A feasibility study using MRI. Laryngoscope 131(3), E851–E856 (2021).
doi: 10.1002/lary.28889 pubmed: 33070337
Park, Y. M., Lim, J. Y., Koh, Y. W., Kim, S. H. & Choi, E. C. Prediction of treatment outcome using MRI radiomics and machine learning in oropharyngeal cancer patients after surgical treatment. Oral. Oncol. 122, 105559 (2021).
doi: 10.1016/j.oraloncology.2021.105559
Suh, C. H. et al. Oropharyngeal squamous cell carcinoma: Radiomic machine-learning classifiers from multiparametric MR images for determination of HPV infection status. Sci. Rep. 10(1), 17525 (2020).
doi: 10.1038/s41598-020-74479-x pubmed: 33067484 pmcid: 7568530
Bos, P. et al. Clinical variables and magnetic resonance imaging-based radiomics predict human papillomavirus status of oropharyngeal cancer. Head Neck. 43(2), 485–495 (2021).
doi: 10.1002/hed.26505 pubmed: 33029923
Spadarella, G. et al. The impact of radiomics for human papillomavirus status prediction in oropharyngeal cancer: Systematic review and radiomics quality score assessment. Neuroradiology 64(8), 1639–1647 (2022).
doi: 10.1007/s00234-022-02959-0 pubmed: 35459957 pmcid: 9271107
Bruixola, G. et al. Radiomics and radiogenomics in head and neck squamous cell carcinoma: Potential contribution to patient management and challenges. Cancer Treat. Rev. 1(99), 102263 (2021).
doi: 10.1016/j.ctrv.2021.102263
Leijenaar, R. T. et al. Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: A multicenter study. Br. J. Radiol. 91(1086), 20170498 (2018).
doi: 10.1259/bjr.20170498 pubmed: 29451412 pmcid: 6223271
Lang, D. M., Peeken, J. C., Combs, S. E., Wilkens, J. J. & Bartzsch, S. Deep learning based HPV status prediction for oropharyngeal cancer patients. Cancers 13(4), 786 (2021).
doi: 10.3390/cancers13040786 pubmed: 33668646 pmcid: 7917758
Bagher-Ebadian, H. et al. Application of radiomics for the prediction of HPV status for patients with head and neck cancers. Med. Phys. 47(2), 563–575 (2020).
doi: 10.1002/mp.13977 pubmed: 31853980
Ren, J., Yuan, Y., Qi, M. & Tao, X. Machine learning–based CT texture analysis to predict HPV status in oropharyngeal squamous cell carcinoma: comparison of 2D and 3D segmentation. Eur. Radiol. 30(12), 6858–6866 (2020).
doi: 10.1007/s00330-020-07011-4 pubmed: 32591885
Saint-Esteven, A. L. G. et al. A 2.5 D convolutional neural network for HPV prediction in advanced oropharyngeal cancer. Comput. Biol. Med. 142, 105215 (2022).
doi: 10.1016/j.compbiomed.2022.105215
Bagher-Ebadian, H. et al. Radiomics outperforms clinical factors in characterizing human papilloma virus (HPV) for patients with oropharyngeal squamous cell carcinomas. Biomed. Phys. Eng. Express 8(4), 045010 (2022).
doi: 10.1088/2057-1976/ac39ab
Jia, X., Ren, L. & Cai, J. Clinical implementation of AI technologies will require interpretable AI models. Med. Phys. 47(1), 1–4 (2020).
doi: 10.1002/mp.13891 pubmed: 31663612
Meijering, E. A bird’s-eye view of deep learning in bioimage analysis. Comput. Struct. Biotechnol. J. 18, 2312–2325 (2020).
doi: 10.1016/j.csbj.2020.08.003 pubmed: 32994890 pmcid: 7494605
Shen, D., Wu, G. & Suk, H. I. Deep learning in medical image analysis. Ann. Rev. Biomed. Eng. 19, 221–248 (2017).
doi: 10.1146/annurev-bioeng-071516-044442
Van der Velden, B. H., Kuijf, H. J., Gilhuijs, K. G. & Viergever, M. A. Explainable artificial intelligence (XAI) in deep learning-based medical image analysis. Med. Image Anal. 1(79), 102470 (2022).
doi: 10.1016/j.media.2022.102470
Nazir, S., Dickson, D. M. & Akram, M. U. Survey of explainable artificial intelligence techniques for biomedical imaging with deep neural networks. Comput. Biol. Med. 1(156), 106668 (2023).
doi: 10.1016/j.compbiomed.2023.106668
Kwan, J. Y. Y. et al. Data from Radiomic Biomarkers to Refine Risk Models for Distant Metastasis in Oropharyngeal Carcinoma; The Cancer Imaging Archive: Manchester (NH, 2019).
Kwan, J. Y. Y. et al. Radiomic biomarkers to refine risk models for distant metastasis in HPV-related oropharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 102, 1107–1116 (2018).
doi: 10.1016/j.ijrobp.2018.01.057 pubmed: 29506884
Clark, K. et al. The Cancer Imaging Archive (TCIA): Maintaining and operating a public information repository. J. Digit. Imaging 26, 1045–1057 (2013).
doi: 10.1007/s10278-013-9622-7 pubmed: 23884657 pmcid: 3824915
Szegedy, C., Vincent V., Sergey I., Jon S. and Zbigniew W. Rethinking the inception architecture for computer vision. In Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition, pp. 2818–2826. (2016)
Kingma, D., and Jimmy B. Adam: A method for stochastic optimization. arXiv preprint arXiv:1412.6980  (2014).
Youden, W. J. Index for rating diagnostic tests. Cancer. 3, 32–35 (1950).
doi: 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3 pubmed: 15405679
Taylor, L., & Nitschke, G. Improving deep learning with generic data augmentation. In 2018 IEEE symposium series on computational intelligence (SSCI) (pp. 1542–1547). IEEE. (2018)
Selvaraju, R.R., Cogswell, M., Das, A., Vedantam, R., Parikh, D., & Batra, D. Grad-cam: Visual explanations from deep networks via gradient-based localization. In Proceedings of the IEEE international conference on computer vision (pp. 618–626). (2017).
Vinogradova, K., Dibrov, A. & Myers, G. Towards interpretable semantic segmentation via gradient-weighted class activation mapping. Proceed. AAAI Conf. Artif. Intell. 34(10), 13943–13944 (2020).
Gillison, M. L., Chaturvedi, A. K., Anderson, W. F. & Fakhry, C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J. Clin. Oncol. 33(29), 3235–3242 (2015).
doi: 10.1200/JCO.2015.61.6995 pubmed: 26351338 pmcid: 4979086
Gillison, M. L. et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92, 709–720 (2000).
doi: 10.1093/jnci/92.9.709 pubmed: 10793107
Schache, A. G. et al. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: Ensitivity, specificity, and prognostic discrimination. Clin. Cancer Res. 17, 6262–6271 (2011).
doi: 10.1158/1078-0432.CCR-11-0388 pubmed: 21969383 pmcid: 3188400
Jordan, R. C. et al. Validation of methods for oropharyngeal cancer HPV status determination in United States cooperative group trials. Am. J. Surg. Pathol. 36, 945 (2012).
doi: 10.1097/PAS.0b013e318253a2d1 pubmed: 22743284 pmcid: 6362985
Simoens, C. et al. Accuracy of high-risk HPV DNA PCR, p16 (INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer. BMC Infect. Dis. 22(1), 676 (2022).
doi: 10.1186/s12879-022-07654-2 pubmed: 35933382 pmcid: 9357318
Buch, K. et al. Using texture analysis to determine human papillomavirus status of oropharyngeal squamous cell carcinomas on CT. AJNR Am. J. Neuroradiol. 36, 1343–1348 (2015).
doi: 10.3174/ajnr.A4285 pubmed: 25836725 pmcid: 7965289
Bogowicz, M. et al. Computed radiomics predicts HPV status and local tumor control after definitive radiochemotherapy in head and neck squamous cell carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 99, 921–928 (2017).
doi: 10.1016/j.ijrobp.2017.06.002 pubmed: 28807534
Chan, M. W. et al. Morphologic and topographic radiologic features of human papillomavirus-related and-unrelated oropharyngeal carcinoma. Head Neck 39, 1524 (2017).
doi: 10.1002/hed.24764 pubmed: 28580605
Fanizzi, A. et al. Transfer learning approach based on computed tomography images for predicting late xerostomia after radiotherapy in patients with oropharyngeal cancer. Front. Med. 9, 993395 (2022).
doi: 10.3389/fmed.2022.993395

Auteurs

Annarita Fanizzi (A)

Laboratorio Biostatistica e Bioinformatica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.

Maria Colomba Comes (MC)

Laboratorio Biostatistica e Bioinformatica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy. m.c.comes@oncologico.bari.it.

Samantha Bove (S)

Laboratorio Biostatistica e Bioinformatica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy. s.bove@oncologico.barit.it.

Elisa Cavalera (E)

Radiation Oncology Unit, Dipartimento di Oncoematologia, Ospedale Vito Fazzi, Lecce, Italy.

Paola de Franco (P)

Radiation Oncology Unit, Dipartimento di Oncoematologia, Ospedale Vito Fazzi, Lecce, Italy.

Alessia Di Rito (A)

Ospedale Monsignor Raffaele Dimiccoli, Barletta, Italy.

Angelo Errico (A)

Ospedale Monsignor Raffaele Dimiccoli, Barletta, Italy.

Marco Lioce (M)

Unità Operativa Complessa di Radioterpia, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.

Francesca Pati (F)

Radiotherapy Department, ASL Brindisi, Brindisi, Italy.

Maurizio Portaluri (M)

Radiotherapy Department, ASL Brindisi, Brindisi, Italy.

Concetta Saponaro (C)

Unità Operativa Complessi di Anatomia Patologia, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.

Giovanni Scognamillo (G)

Unità Operativa Complessa di Radioterpia, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.

Ippolito Troiano (I)

Radiation Oncology Department, Fondazione IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.

Michele Troiano (M)

Radiation Oncology Department, Fondazione IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.

Francesco Alfredo Zito (FA)

Unità Operativa Complessi di Anatomia Patologia, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.

Raffaella Massafra (R)

Laboratorio Biostatistica e Bioinformatica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH